James Robert Osborne, PA-C

James Osborne practices at Ascension St. Vincent's Southside Hospital in Jacksonville, Florida, part of Ascension Health Alliance.

James Osborne's NPI, 1487039178, was assigned on July 23, 2015. James Osborne holds Florida license PA9108777.

James Osborne's primary practice is Ascension St. Vincent's Southside Hospital, at 4201 Belfort Rd, Jacksonville, FL 32216 in Duval County. The practice phone is (904) 296-3700.

James Osborne's primary practice is Ascension St. Vincent's Southside Hospital in Jacksonville, Florida, part of Ascension Health Alliance. James Osborne is also affiliated with Ascension St. Vincent's Riverside. The medical group on file is St. Vincent's Healthcare. Dmand AI also links James Osborne to 2 more hospitals, 2 home health agencies and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where James Osborne practices, 6 sites in all. Vendor and product names are available with a free account.

Medical is James Osborne's primary specialty in the NPI Registry, under taxonomy code 363AM0700X. James Osborne is board certified in certified physician assistant by the National Commission on Certification of Physician Assistants (NCCPA). James Osborne is licensed in Florida.

Dmand AI lists anxiety, chronic nasal allergies, corns and calluses, depression, diabetic emergency, enlarged prostate, fibromyalgia and chronic pain and fluid and electrolyte imbalances among the conditions James Osborne treats.

CMS data shows 438 Medicare services from James Osborne across 6 procedure codes in 2024, for 129 Medicare patients. Medicare paid $24,485 for them. Every service was in an office.

CMS counts 129 Medicare patients who saw James Osborne in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.22, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts James Osborne's median patient age at 64, with 57% women.

In 2024, James Osborne wrote 4,439 Medicare Part D claims for 354 patients. 87% of them were for generic drugs. CMS names the drug for 3,777 of them, across 90 drugs with 11 or more claims each, at $300,072 in total drug cost.

James Osborne accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists James Osborne as offering telehealth.

CMS Open Payments shows 1 general payment to James Osborne from 1 drug or device company in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $24.